Back to Search
Start Over
LOW-DOSE VALGANCICLOVIR FOR 3 MONTHS PREVENTS CYTOMEGALOVIRUS (CMV) DISEASE IN RENAL AND PANCREAS TRANSPLANT RECIPIENTS, INCLUDING RECIPIENTS AT HIGH-RISK FOR CMV DISEASE.
- Source :
- Transplantation; 2006 Supplement, Vol. 82, p585-586, 2p
- Publication Year :
- 2006
Details
- Language :
- English
- ISSN :
- 00411337
- Volume :
- 82
- Database :
- Complementary Index
- Journal :
- Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 114954487